All Stories

  1. Smell Above All: Envisioning Smell-Centred Future Worlds
  2. Prevalence and Associated Factors of Medication Non-Adherence in CRS Patients following Endoscopic Sinus Surgery
  3. Understanding the Impact of Chronic Rhinosinusitis with Nasal Polyposis on Smell and Taste: An International Patient Experience Survey
  4. Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
  5. Exploring Endotypes in Chronic Rhinosinusitis (ExpRess): Protocol for a cohort study
  6. Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
  7. Impact of olfactory disorders on personal safety & wellbeing: a cross-sectional observational study
  8. Developing a core outcome set for clinical trials in olfactory disorders: a COMET initiative
  9. Nose Gym: An Interactive Smell Training Solution
  10. Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination
  11. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  12. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
  13. Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders
  14. Olfactory Disorders Questionnaire: Scaling severity of quality‐of‐life impact
  15. The growing burden of long COVID in the United Kingdom: Insights from the UK Coronavirus Infection Survey
  16. The EUFOREA pocket guide for chronic rhinosinusitis
  17. High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID‐19) pandemic in the United States: Urgent need for clinical trials
  18. Investigations and Outcomes for Olfactory Disorders
  19. Manipulation under anaesthesia of fractured nasal bones – a 10-year retrospective study
  20. The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom
  21. Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
  22. Establishing UK research priorities in smell and taste disorders: A James Lind alliance priority setting partnership
  23. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  24. The use of MRI in a tertiary smell and taste clinic: Lessons learned based on a retrospective analysis
  25. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
  26. Whole exome sequencing study identifies candidate loss of function variants and locus heterogeneity in familial cholesteatoma
  27. The COVANOS trial – insight into post-COVID olfactory dysfunction and the role of smell training
  28. When is Magnetic Resonance Imaging most beneficial in olfactory dysfunction? A retrospective review of a tertiary referral smell and taste clinic
  29. Establishing UK Research Priorities In Smell and Taste Disorders: A James Lind Alliance Priority Setting Partnership
  30. A follow-up on quantitative and qualitative olfactory dysfunction and other symptoms in patients recovering from COVID-19 smell loss
  31. International consensus statement on allergy and rhinology: Olfaction
  32. Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis
  33. Interventions for the treatment of persistent post-viral olfactory dysfunction
  34. Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
  35. Olfaction and CSF Leak
  36. 918 Nasal Packing Duration in The Management of Epistaxis: A Cohort Study
  37. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  38. Cultural Adaptation and Validity of the Sniffin’ Sticks Psychophysical Test for the UK Setting
  39. Barriers to effective health care for patients who have smell or taste disorders
  40. Patient perspectives about participation in a chronic rhinosinusitis trial during the COVID pandemic: a qualitative study.
  41. Clinical Olfactory Working Group consensus statement on the treatment of postinfectious olfactory dysfunction
  42. British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps
  43. Socioeconomic, comorbidity, lifestyle, and quality of life comparisons between chronic rhinosinusitis phenotypes
  44. Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view
  45. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  46. International consensus statement on allergy and rhinology: rhinosinusitis 2021
  47. Barriers to Effective Healthcare for Patients Who Have Smell or Taste Disorders
  48. British Rhinological Society Consensus Guidance on the use of biological therapies for Chronic Rhinosinusitis with Nasal Polyps
  49. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  50. Admission avoidance in acute epistaxis: A prospective national audit during the initial peak of the COVID‐19 pandemic
  51. Health-Related Quality of Life Impairment Among Patients With Severe Chronic Rhinosinusitis With Nasal Polyps in the SINUS-24 Trial
  52. Evaluation of Smoking as a Modifying Factor in Chronic Rhinosinusitis
  53. Paediatric tonsillectomy in England: A cohort study of clinical practice and outcomes using Hospital Episode Statistics data (2008‐2019)
  54. Maximising recruitment to a randomised controlled trial for chronic rhinosinusitis using qualitative research methods: the MACRO conversation study
  55. A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice
  56. Qualitative Olfactory Disorders: Patient Experiences and Self-Management
  57. Corrigendum to: More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  58. Patient Experiences of Postinfectious Olfactory Dysfunction
  59. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms
  60. Course of symptoms for loss of sense of smell and taste over time in one thousand forty‐one healthcare workers during the Covid‐19 pandemic: Our experience
  61. Admission avoidance in tonsillitis and peritonsillar abscess: A prospective national audit during the initial peak of the COVID‐19 pandemic
  62. Comparison of COVID-19 and common cold chemosensory dysfunction
  63. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training
  64. Socioeconomic, comorbidity, lifestyle and quality of life comparisons between chronic rhinosinusitis phenotypes: Data from the National Chronic Rhinosinusitis Epidemiology Study
  65. Patient Experiences of Post-Infectious Olfactory Dysfunction
  66. Management of new onset loss of sense of smell during the COVID‐19 pandemic ‐ BRS Consensus Guidelines
  67. Is loss of sense of smell a diagnostic marker in COVID‐19: A systematic review and meta‐analysis
  68. Smoking as a modifying factor in chronic rhinosinusitis: Data from the Chronic Rhinosinusitis Epidemiology Study
  69. Olfactory Loss of Function as a Possible Symptom of COVID-19
  70. Defining appropriateness criteria for endoscopic sinus surgery in the management of adult dental implant patients with incidental maxillary sinus findings on conebeam computed tomography
  71. Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection
  72. The best COVID-19 predictor is recent smell loss: a cross-sectional study
  73. Barriers to accessing healthcare in patients with olfactory and gustatory disorders
  74. Qualitative Olfactory Disorders: Patient experiences and self-management
  75. More Than Smell—COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis
  76. Management of new onset anosmia during the COVID pandemic - BRS Consensus Guidelines
  77. Parosmia is associated with relevant olfactory recovery after olfactory training
  78. The impact of patients losing their sense of smell
  79. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers – A systematic review of the literature, case series, and recommendations for clinical assessment and management
  80. Cholesteatoma and family history: An international survey
  81. The Socioeconomic Cost of Chronic Rhinosinusitis Study
  82. Biologics for chronic rhinosinusitis
  83. European Position Paper on Rhinosinusitis and Nasal Polyps 2020
  84. Biologics for chronic rhinosinusitis
  85. An unmet need: Patients with smell and taste disorders
  86. 139 Risk of parkinson’s in idiopathic anosmia
  87. Lacrimal sac primary squamous cell carcinoma with synchronous tonsillar primary squamous cell carcinoma
  88. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
  89. Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records
  90. Optimising trial outcomes and patient retention for the MACRO trial for chronic rhinosinusitis
  91. The genetics of cholesteatoma study. Loss‐of‐function variants in an affected family
  92. What is the most appropriate treatment for chronic rhinosinusitis?
  93. Validation of the olfactory disorders questionnaire for English‐speaking patients with olfactory disorders
  94. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  95. Exploring the association between ingestion of foods with higher potential salicylate content and symptom exacerbation in chronic rhinosinusitis. Data from the National Chronic Rhinosinusitis Epidemiology Study
  96. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial
  97. Expert panel process to optimise the design of a randomised controlled trial in chronic rhinosinusitis (the MACRO programme)
  98. Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care
  99. Unilateral visual loss resulting from orbital encroachment of an ethmoidal juvenile trabecular ossifying fibroma
  100. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records
  101. EPOS2020: development strategy and goals for the latest European Position Paper on Rhinosinusitis
  102. Wooden spatula sinusitis following maxillary expansion surgery
  103. Management strategies for chronic rhinosinusitis: a qualitative study of GP and ENT specialist views of current practice in the UK
  104. Topical and systemic antifungal therapy for chronic rhinosinusitis
  105. Development of an International Odor Identification Test for Children: The Universal Sniff Test
  106. Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study
  107. Saline irrigation for allergic rhinitis
  108. Faculty of 1000 evaluation for Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review.
  109. Eustachian tube symptoms are frequent in chronic rhinosinusitis and respond well to endoscopic sinus surgery
  110. Endonasal Approaches to Maxillary Sinus
  111. The use of nasal sprays and rinses in patients with chronic sinus disease
  112. The British Rhinological Society multidisciplinary consensus recommendations on the hospital management of epistaxis
  113. Initial assessment in the management of adult epistaxis: systematic review
  114. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  115. Health care usage and quality of life reporting in chronic sinusitis patients
  116. The genetics of cholesteatoma. A systematic review using narrative synthesis
  117. Position paper on olfactory dysfunction
  118. Chronic rhinosinusitis and mood disturbance
  119. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders
  120. Saline irrigation for allergic rhinitis
  121. Cochrane Corner: Extracts from The Cochrane Library: Intranasal Steroids for Chronic Rhinosinusitis
  122. CHronic Rhinosinusitis Outcome MEasures (CHROME), developing a core outcome set for trials of interventions in chronic rhinosinusitis
  123. Position paper on olfactory dysfunction
  124. Chronic rhinosinusitis and mood disturbance
  125. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
  126. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  127. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  128. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  129. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  130. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes
  131. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia
  132. Topical and systemic antifungal therapy for chronic rhinosinusitis
  133. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis
  134. SNOT-22 in a control population
  135. Current practice in septal surgery and adjunctive turbinate reduction - A multisite experience in 226 consecutive cases
  136. A case-control study of medical, psychological and socio-economic factors influencing the severity of chronic rhinosinusitis
  137. Genetics of Cholesteatoma Project
  138. Short-course oral steroids alone for chronic rhinosinusitis
  139. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  140. Different types of intranasal steroids for chronic rhinosinusitis
  141. Systemic and topical antibiotics for chronic rhinosinusitis
  142. Saline irrigation for chronic rhinosinusitis
  143. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  144. Chronic rhinosinusitis and mood disturbance
  145. Long term quality of life in patients with fungal sinus disease
  146. Identifying the most important outcomes for systematic reviews of interventions for rhinosinusitis in adults: working with Patients, Public and Practitioners
  147. Chronic rhinosinusitis: patient experiences of primary and secondary care - a qualitative study
  148. Anatomic findings in revision endoscopic sinus surgery: Case series and review of contributory factors
  149. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis
  150. Systemic and topical antibiotics for chronic rhinosinusitis
  151. Saline irrigation for chronic rhinosinusitis
  152. Different types of intranasal steroids for chronic rhinosinusitis
  153. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
  154. Short-course oral steroids alone for chronic rhinosinusitis
  155. Abstracts of the 2015 Annual Meeting 4-6 September 2015 Telford International Centre UK
  156. The impact of commissioning for rhinosinusitis in England
  157. Investigation of nasal diseases
  158. British Rhinological Society 14th Annual Meeting The Central Convention Centre, Manchester. 15th May 2015
  159. The burden of revision sinonasal surgery in the UK--data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study
  160. Hyposmia
  161. Assessing the sense of smell
  162. Cost-Effective Surgical Intervention in Chronic Rhinosinusitis
  163. Bilateral glossopharyngeal nerve palsy following tonsillectomy: a very rare and difficult complication of a common procedure
  164. Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions
  165. Getting involved in ENT clinical research in the UK; how can the NIHR Clinical Research Network help?
  166. The Impact of Olfactory Disorders in the United Kingdom
  167. Chronic Rhinosinusitis and Mood Disturbance
  168. Management of CRSwNPs Surgically
  169. Olfactory Improvement and Decline in Patients with Posttraumatic Olfactory Dysfunction
  170. SNOT-22 in a Control Population
  171. Anatomy and Physiology of the Olfactory and Gustatory Systems
  172. Cerebrospinal Fluid Rhinorrhoea
  173. Ciliary Motility Disorders
  174. Clinical Governance and Audit
  175. Complications of Sinusitis
  176. Endoscopic Sinus Surgery and Complications
  177. Epistaxis
  178. European Position Paper on Rhinosinusitis and Nasal Polyps
  179. Facial Flaps, Scars, and Keloids
  180. Facial Fractures and Swelling
  181. Fungal Sinus Disease
  182. Headache and Facial Pain
  183. Medical Statistics
  184. Microbiology of ENT
  185. Olfactory and Gustatory Disorders
  186. Sinonasal Anatomy and Physiology
  187. Tumours of the Nose and Paranasal Sinuses
  188. Retronasal testing of olfactory function: an investigation and comparison in seven countries
  189. Using a passive coordinate measurement arm for motion tracking of a rigid endoscope for augmented-reality image-guided surgery
  190. Unilateral cacosmia: a presentation of maxillary fungal infestation
  191. When mealtime is the most dreaded moment of your day
  192. Pneumatisation of turbinates and paranasal sinuses in children: case report
  193. A double-blinded randomised controlled trial of the effects of sodium citrate on olfactory thresholds
  194. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  195. Epistaxis Secondary to an Oncocytoma of the Anterior Skull Base
  196. Skull base oncocytoma presenting as epistaxis: an unusual presentation of a rare tumour successfully managed with active surveillance
  197. A useful tool - systematic checklist for evaluating sinus scans
  198. Validation study of the “Sniffin’ Sticks” olfactory test in a British population: a preliminary communication
  199. A double-blind randomised controlled trial of gloved versus ungloved merocel middle meatal spacers for endoscopic sinus surgery
  200. Allergic fungal rhinosinusitis - a new staging system
  201. Allergic fungal rhinosinusitis - a new staging system
  202. Olfactory Dysfunction in Allergic Fungal Rhinosinusitis
  203. Selecting the Best Approach to the Frontal Sinus
  204. Nanomedicine in otorhinolaryngology: what does the future hold?
  205. Endoscopic management of inverted papillomas: long-term results, the St. Pauls Sinus Centre experience
  206. Endoscopic frontal sinusotomy-Preventing recurrence or a route to revision?
  207. Tumefactive fibroinflammatory lesion of the frontal sinus
  208. The Leicester semi-automated olfactory threshold test--a psychophysical olfactory test for the 21st century
  209. SUBJECTS AND METHODS
  210. Periorbital oedema and surgical emphysema, an unusual complication of a dental procedure: a case report
  211. Proximal Lacrimal Obstruction – A Review
  212. The superosmic phenomenon
  213. The Leicester Olfactometer
  214. Does methicillin-resistantStaphylococcus aureushave a significant role in the peri-operative course of patients undergoing rhinological surgery?
  215. ENT cases seen at a local ‘walk-in centre’: a one year review
  216. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology?
  217. A brief history of olfaction and olfactometry
  218. The superosmic phenomenon
  219. Olfactory clearance: what time is needed in clinical practice?
  220. The Effect of Female Hormone Manipulation on Nasal Physiology
  221. R142: The Effects of Sensory Deprivation on Olfactory Thresholds
  222. R152: Olfactory Adaptation and Clearance in Clinical Practice
  223. Bronchiectasis and sino-nasal disease: a review
  224. What is the short term effect of perfumes on olfactory thresholds?
  225. Which variables matter in smell tests in the clinic?
  226. Does the benefit of adenoidectomy in addition to ventilation tube insertion persist long-term?
  227. Methicillin resistant Staphylococcus aureus: is it a problem for nasal surgery?
  228. Randomised-controlled study comparing post-operative pain between coblation palatoplasty and laser palatoplasty
  229. Comparison of Subjective Perception with Objective Measurement of Olfaction
  230. Response to Rachmanidou
  231. Timing of tracheostomy in adult patients: Potential ramifications are alarming
  232. Variability of vascularity in nasal mucosa as demonstrated by CD34 immunohistochemistry
  233. Do our Noses Lead Us Away from the Scent?
  234. Superosmia: A New Vomeronasal Organ Mediated Phenomenon?
  235. A double-blinded randomized controlled trial of coblation versus conventional dissection tonsillectomy on post- operative symptoms
  236. Is there a role for more day-case septal surgery?
  237. Erratum
  238. Canalicular adenoma of the parotid gland
  239. Paediatric retropharyngeal abscess
  240. Which solvent for olfactory testing?
  241. Nasal physiological changes during pregnancy
  242. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle1
  243. The effect of temperature, humidity and peak inspiratory nasal flow on olfactory thresholds
  244. Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates
  245. Subjects and methods
  246. Hyposmia